Clinical trial

Pantoprazole Prophylaxis Against Delayed CINV for Patients Receiving Breast Cancer Chemotherapy

NCT03948477

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-06-10

PhasePHASE2

Study timeline

Study start (actual)2019-06-10Date precision: day

Registry last updated2022-05-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Oncologyunresolved

Breast Cancerunresolved

Chemotherapy-induced Nausea and Vomitingunresolved

Interventions

Pantoprazole 40mgDRUG

PlaceboDRUG

Sponsors & collaborators

University of Auckland, New Zealandlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03948477 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.